Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
ZK53: Practical ClpP Assay Design for Cell Studies
2026-08-11
Learn how ZK53 (SKU BA8004) can improve interpretation of cell viability, proliferation, and mitochondrial stress experiments through assay-specific potency data and defined biological mechanisms. This scenario-based guide covers dose selection, species compatibility, ferroptosis studies, and evidence-based product evaluation.
-
RSL3, PARP1, and Ferroptosis–Apoptosis Crosstalk
2026-08-11
The 2025 study identifies PARP1 as a mechanistic bridge between RSL3-induced ferroptosis and apoptosis, revealing both caspase-dependent PARP1 cleavage and loss of full-length PARP1 through disrupted METTL3-mediated m6A regulation. Its findings suggest that RSL3 can retain pro-apoptotic activity in PARP-inhibitor-resistant tumors and provide a framework for separating ferroptotic and apoptotic outputs in cell-death research.
-
Dehydroabietic Acid: From Target to Assay
2026-08-10
Dehydroabietic acid offers a practical way to study dual PPAR-α/γ agonism alongside adipocyte gene regulation. This guide connects receptor pharmacology with the targeted CRISPRi findings of Chung et al. to improve assay design, controls, and interpretation in metabolic disorder research.
-
IPR-803: From uPAR Binding to Assay Design
2026-08-09
IPR-803 is a urokinase receptor inhibitor for dissecting uPAR–uPA biology in invasion, metastasis, and tumor-microenvironment studies. This guide distinguishes direct biochemical activity from context-dependent cellular effects and translates the evidence into better assay decisions.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-08
This guide explains how to use Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 for HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for research workflows only; no directly matched paper evidence or diagnostic, therapeutic, or medical-use validation is supplied here.
-
BRCA2-Dependent Nascent Strand Maturation with Olaparib
2026-08-07
Milano et al. identify a BRCA2- and RAD51-associated pathway that promotes maturation or repair of nascent DNA strands during PARP inhibition. The study links olaparib-induced replication-associated gaps to a post-replicative repair process, refining how PARP inhibitor sensitivity and BRCA-associated cancer targeted therapy may be interpreted.
-
Isorhamnetin: Optimizing Oocyte Maturation via PI3K/Akt Path
2026-08-07
Isorhamnetin empowers researchers to mitigate oxidative stress and boost oocyte maturation by modulating PI3K/Akt signaling. With APExBIO’s high-purity reagent, precise protocol execution and reliable results are within reach for advanced cellular and reproductive studies.
-
Antimycin A4 as an ATP-Citrate Lyase Inhibitor: Workflows &
2026-08-06
Antimycin A4 uniquely couples ATP-citrate lyase inhibition with targeted disruption of mitochondrial respiration, making it a dual-action tool for dissecting cellular energy pathways and lipid biosynthesis. This article delivers actionable experimental workflows, troubleshooting guidance, and protocol parameters to maximize reproducibility with APExBIO’s Antimycin A4.
-
5X Protein Loading Buffer (Reducing): SDS-PAGE Workflow Guid
2026-08-06
5X Protein Loading Buffer (Reducing) is designed for accurate protein separation by molecular weight in SDS-PAGE, ensuring comprehensive denaturation and reduction of disulfide bonds. It should be used in workflows that require reducing conditions, and is not suitable for protocols that aim to preserve native protein structure or non-reducing environments.
-
Mechanisms of Cell Death in Heart Disease: Insights and Tool
2026-08-05
This article analyzes how apoptosis and necrosis—both regulated and unregulated—underpin the pathology of heart disease, as detailed in the reference study. We examine the paper’s methodological advances, key findings, and implications for experimental models, highlighting their relevance for cross-disease research on fibrosis and inflammation.
-
Potassium Iodide: Bridging Thyroid Protection and Tumor Immu
2026-08-05
This thought-leadership article explores the evolving role of Potassium Iodide (KI) in translational research, from classic thyroid protection to cutting-edge immunotherapy workflows. By weaving mechanistic insight, protocol guidance, and strategic context, it empowers researchers to leverage KI for both endocrine and tumor microenvironment modulation, highlighting key evidence, product intelligence from APExBIO, and emerging nanotechnology-driven synergies.
-
Optimizing PTEN Restoration: EZ Cap™ Human PTEN mRNA in Canc
2026-08-04
This article explores practical laboratory scenarios where EZ Cap™ Human PTEN mRNA (SKU R1025) addresses core challenges in tumor suppressor gene restoration, experimental reproducibility, and mRNA delivery. Drawing on recent evidence and validated protocols, it demonstrates how this reagent enhances data reliability and workflow efficiency for biomedical researchers.
-
HEY2 Regulates Cardiac Mitochondrial Respiration and Homeost
2026-08-04
This study uncovers the role of the transcriptional repressor HEY2 in dampening mitochondrial oxidative respiration to maintain cardiac homeostasis. By integrating genome-wide analyses and functional experiments in mammalian and zebrafish models, the authors reveal an evolutionarily conserved HEY2/HDAC1-Ppargc1/Cpt regulatory axis critical for cardiomyocyte energy metabolism and heart failure pathogenesis.
-
Q-VD(OMe)-OPh: Precision Caspase Inhibition in Apoptosis Ass
2026-08-03
Q-VD(OMe)-OPh, a potent pan-caspase inhibitor, enables high-fidelity apoptosis research with minimal cytotoxicity, surpassing traditional inhibitors. Its application streamlines workflows in cancer, neuroprotection, and cell differentiation models, offering researchers superior reproducibility and selectivity.
-
Applied Workflows for Diuron (3-(3,4-dichlorophenyl)-1,1-dim
2026-08-03
Harness the reproducibility and high purity of Diuron for advanced plant biology and environmental toxicology studies. This guide demystifies experimental design, troubleshooting, and protocol optimization, leveraging the latest mechanistic insights to streamline your research.